roadcast Date: January 21st, 2015
Time: 1 PM ET, 10 AM PT
Whole genome sequencing (WGS) is well on its way to transforming medicine. However, there are a few bumps on the road that WGS needs to overcome before it can become a broadly used and increasingly effective tool for the clinic. Current limitations include the need for WGS tests to be more reliable, demonstrate a better ability to capture the entire genome, and improve its predictive capabilities, which right now hinder the task of interpreting the results.
This GEN webinar will focus on scientific, clinical, and patient-oriented strategies to help WGS meet its high clinical expectations. Topics to be covered include whole genome sequencing strengths and weaknesses, transitioning from exome sequencing quality concerns and clinical utility to complementary issues with WGS, patients’ views on costs vs. benefits of WGS, potential risks associated with discrimination resulting from WGS data, regulatory and reimbursement issues, and themes revolving around privacy and patient ownership of WGS data. During the webinar Dr. David Smith will also point out specific clinical indications for which whole genome sequencing might be appropriate, Dr. Jason Park will talk about the need for improved standards covering whole genome sequencing and other techniques used in genomic medicine, and James O’Leary will provide the patient’s perspective on whole genome sequencing in the clinic.
Who Should Attend
- Molecular geneticists
- Sequencing scientists
You Will Learn
- How to better understand the challenges and eliminate bottlenecks that are limiting the success of whole genome sequencing in the clinic.
- How to overcome the knowledge gaps and specific technical issues that might help you push forward with your own clinical whole genome sequencing.
- How to interact with patients and patient advocates to address any concerns they might express about having their genomic profiles characterized in a clinical setting.
- What are the pluses and minuses of specific instruments currently being used to carry out whole genome sequencing.
Produced with support from:
David Smith, Ph.D.
Professor of Laboratory Medicine and Pathology,
Jason Y. Park, M.D., Ph.D.
UT Southwestern Medical Center
Chief Innovation Officer,